Nox Health Acquires Somryst from Pear Therapeutics

May 25, 2023

Nox Health, a global sleep health company based in Alpharetta, Georgia, has acquired Somryst—the FDA-cleared prescription digital therapeutic for chronic insomnia—purchased from Pear Therapeutics. The acquisition brings an outcomes-validated insomnia treatment into Nox's value-based sleep care programs to expand its clinical offerings for employers, health plans and health systems.

Buyers
Nox Health
Targets
Somryst
Sellers
Pear Therapeutics
Location
Massachusetts, United States
Transaction Type
Divestiture

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.